Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Grenier, , Pauline,
DOB: 03-MAY-1971 (Age: 54)
Gender: female
Address:
114, avenue Georges
71110 Caron (France)
ID: 6776-872657-1 (ECI)
Report
Date: 30-JAN-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Hôpital du Creusot - Site Foch
71200 Le Creusot (France)
Specimen
Collected: 30-JAN-2017

Chemistry

Test 30-JAN-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 74.7 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 10.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.6 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.0 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.0 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 105.0 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 20.8 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 194.9 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 149.0 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 113.0 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 52.2 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, suggesting prediabetes or impaired glucose tolerance, while fasting glucose is normal. All renal, electrolyte, and lipid parameters are within normal limits except for a slightly low total CO₂, which may indicate mild metabolic acidosis or compensation. No acute abnormalities detected; recommend monitoring glycemic control and considering further evaluation of acid-base status if clinically indicated.